Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04254159
Other study ID # ElifD
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date December 5, 2019
Est. completion date May 22, 2020

Study information

Verified date February 2022
Source Yeditepe University
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The aim of the randomized controlled study is to investigate the effects of NMES superimposed on voluntary contraction combined with patient education and exercise training program in patients with chronic obstructive pulmonary disease.


Description:

When initial assessments will be completed, patients will be assigned to one of two possible sequences by simple randomization: Superimposed NMES group (SG) or control group (CG). All volunteers will receive an COPD patient education program for once and conventional physiotherapy exercise program for COPD with the duration of 8 weeks. Additionally, superimposed NMES will be applied on quadriceps muscle of both limbs at the same time with voluntarily contraction of quadriceps muscle in SG. All patients will be assessed in terms of functional capacity, pulmonary functions, quadriceps muscle endurance and strength, dyspnea, respiratory muscle strength and quality of life at the baseline and at the end of study. Data will be collected from all the patients at baseline and at the end of study (8 weeks) by the same physiotherapist who also will supervise the exercise sessions.


Recruitment information / eligibility

Status Completed
Enrollment 24
Est. completion date May 22, 2020
Est. primary completion date February 2, 2020
Accepts healthy volunteers No
Gender All
Age group 65 Years to 75 Years
Eligibility Inclusion Criteria: 1. Having stable asthma 2. Participating to the study in a voluntary basis 3. Being 65 - 75 years old 4. Having 2 point or over score from "Modified Medical Research Council (MMRC)" Dyspnea Scale 5. Being motivated to participate and follow exercise program Exclusion Criteria: 1. Having an asthma exacerbation in a last month 2. Other respiratory problems 3. Ischemic heart disease 4. Congestive heart disease 5. Pacemaker 6. Acute Cor Pulmonale 7. Neurological Diseases 8. Osteoporosis 9. Smoking

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Superimposed Neuromuscular Electrical Stimulation
NMES will be applied during each strengthening exercise session. A dual channel NMES stimulation device will be used with biphasic symmetric constant current impulses with a pulse width 300ms, a frequency of 50 Hz and a duty cycle of 10s on and 20s off protocol for 3 days a week for eight weeks.
Quadriceps Strengthening
Quadriceps strength training will be done with resistive elastics bands for 3 days a week for eight weeks.
Behavioral:
Patient Education Program
The aim of patient education is to increase awareness of patients about COPD and develop skills to better manage their disease. The patient education will be performed at least once via face to face interview. Education topics will be covered basic information about COPD, environmental risk factors, monitoring and managing the signs and symptoms of their disease, energy conservation techniques and relaxation positions to reduce dyspnea and usage of a specific inhaler.
Other:
Aerobic Exercise Training
Exercise training will be comprised of cardiovascular endurance training with cycle ergometer and lower extremity strength training. The exercises will be done 3 days a week at the clinic under the supervision of physiotherapist. Total duration of exercise training will last for 8 weeks

Locations

Country Name City State
Turkey Kadiköy Municipality Social Life Center Istanbul Kadiköy

Sponsors (2)

Lead Sponsor Collaborator
Yeditepe University Kadikoy Municipality Social Life Center

Country where clinical trial is conducted

Turkey, 

Outcome

Type Measure Description Time frame Safety issue
Primary Sit to Stand Test Quadriceps muscle endurance will be evaluated with this test 8 weeks
Primary Muscle Strength Test Jtech Commander Power Track Muscle Testing Dynamometer, USA which quantifies muscle power will be used to assess the maximum voluntary contractions of quadriceps muscle in pound meter. 8 weeks
Primary Six Minute Walking Test Six-Minute Walking Test (6MWT) was used to evaluate functional capacity of volunteers. 8 weeks
Primary Asthma Quality of Life Scale (AQOL) Asthma quality of life questionnaire will utilize to assess quality of life of participants over two weeks prior to interview which is validated in Turkish population by Alpaydin et al. 8 weeks
Secondary Modified Medical Research Council (MMRC) Dyspnea Scale Perceived dyspnea which is any restrictions performing daily living activities will be measured by MMRC dyspnea scale. 8 weeks
Secondary Physical Activity Questionnaire for Elderly (PASE) We will assess the physical activity status of the oler patients with asthma by using Physical Activity Questionnaire for Elderly (PASE). 8 weeks
Secondary Time Up and Go Test Time Up and Go Test (TUG) will be used to evaluate the risk for falling in older patients with asthma. 8 weeks
Secondary Pulmonary Function Test Medical International Research Spirodoc® Spiro, Italy brand named spirometry will be used to evaluate pulmonary functions of volunteers. 8 weeks
Secondary Respiratory Muscle Strength Testing The Micro Medical Micro RPM, England respiratory pressure meter will be utilized to measure respiratory muscle strength. 8 weeks
See also
  Status Clinical Trial Phase
Completed NCT04624425 - Additional Effects of Segmental Breathing In Asthma N/A
Terminated NCT04410523 - Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma Phase 2
Active, not recruiting NCT03927820 - A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR) N/A
Completed NCT04617015 - Defining and Treating Depression-related Asthma Early Phase 1
Recruiting NCT03694158 - Investigating Dupilumab's Effect in Asthma by Genotype Phase 4
Terminated NCT04946318 - Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma Phase 2
Completed NCT04450108 - Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients N/A
Completed NCT03086460 - A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH) Phase 2
Completed NCT01160224 - Oral GW766944 (Oral CCR3 Antagonist) Phase 2
Completed NCT03186209 - Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE) Phase 3
Completed NCT02502734 - Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma Phase 3
Completed NCT01715844 - L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics Phase 1
Terminated NCT04993443 - First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036 Phase 1
Completed NCT02787863 - Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology Phase 4
Recruiting NCT06033833 - Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study Phase 2
Completed NCT03257995 - Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma. Phase 2
Completed NCT02212483 - Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients N/A
Recruiting NCT04872309 - MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
Withdrawn NCT01468805 - Childhood Asthma Reduction Study N/A
Recruiting NCT05145894 - Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device